01.10.2014 | Letter to the Editors
First reported case of diabetes mellitus type 1 as a possible secondary autoimmune disease following alemtuzumab treatment in MS
Erschienen in: Journal of Neurology | Ausgabe 10/2014
Einloggen, um Zugang zu erhalten